Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity
Rebekah Watkins-Schulz, Pamela Tiet, Matthew D. Gallovic, et al.
Biomaterials (2019) Vol. 205, pp. 94-105
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy via Enhancing Innate Immunity
Lin Hou, Chunyu Tian, Yingshan Yan, et al.
ACS Nano (2020) Vol. 14, Iss. 4, pp. 3927-3940
Closed Access | Times Cited: 254
cGAS-STING pathway in cancer biotherapy
Yang Wang, Jingwen Luo, Aqu Alu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 243
STING activation in cancer immunotherapy
Ting Su, Yu Zhang, Kristoffer Valerie, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7759-7771
Open Access | Times Cited: 205
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
Leila Motedayеn Aval, James E. Pease, Rohini Sharma, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3323-3323
Open Access | Times Cited: 179
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles
Pere Dosta, Alexander M. Cryer, Michelle Z. Dion, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 11, pp. 1351-1363
Closed Access | Times Cited: 79
cGAS–STING, an important signaling pathway in diseases and their therapy
Qijie Li, Ping Wu, Qiujing Du, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 23
Chemical Strategies to Boost Cancer Vaccines
Wenhao Li, Yanmei Li
Chemical Reviews (2020) Vol. 120, Iss. 20, pp. 11420-11478
Closed Access | Times Cited: 126
Electrospray for generation of drug delivery and vaccine particles applied in vitro and in vivo
Rebeca T. Steipel, Matthew D. Gallovic, Cole J. Batty, et al.
Materials Science and Engineering C (2019) Vol. 105, pp. 110070-110070
Open Access | Times Cited: 79
The Age of Cyclic Dinucleotide Vaccine Adjuvants
Himanshu Gogoi, Samira Mansouri, Lei Jin
Vaccines (2020) Vol. 8, Iss. 3, pp. 453-453
Open Access | Times Cited: 79
Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
Jia Zhuang, Maya Holay, Joon Ho Park, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7826-7848
Open Access | Times Cited: 78
Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
Kathleen M. McAndrews, Sara P.Y., Valerie S. LeBleu, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100523-100523
Open Access | Times Cited: 61
Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy
Meixiao Zhan, Xiangrong Yu, Wei Zhao, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Ruthenium complexes boost NK cell immunotherapy via sensitizing triple-negative breast cancer and shaping immuno-microenvironment
Qi Chen, Lizhen He, M Kellis, et al.
Biomaterials (2022) Vol. 281, pp. 121371-121371
Closed Access | Times Cited: 47
Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
Cuiqing Huang, Ni Shao, Yanyu Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100839-100839
Open Access | Times Cited: 37
Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
Jia Wei, Xiaofeng Lu, Qin Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Endoplasmic Reticulum-Targeted Polymer-Manganese Nanocomplexes for Tumor Immunotherapy
Haoru Zhu, Chang Xu, Yu Geng, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Profile of STING agonist and inhibitor research: a bibliometric analysis
Xuemei Wang, Qian Wang, Yidan Gao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review
Benedetta Pellegrino, Antonino Musolino, Alba Llop‐Guevara, et al.
Translational Oncology (2020) Vol. 13, Iss. 2, pp. 410-422
Open Access | Times Cited: 62
Carbohydrate Conjugates in Vaccine Developments
Shuyao Lang, Xuefei Huang
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 59
Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy
Shuyan Han, Keqing Huang, Zhipeng Gu, et al.
Nanoscale (2019) Vol. 12, Iss. 2, pp. 413-436
Closed Access | Times Cited: 58
Cytosolic Delivery of Thiolated Mn‐cGAMP Nanovaccine to Enhance the Antitumor Immune Responses
Chengyun Chen, Yuhong Tong, Youshi Zheng, et al.
Small (2021) Vol. 17, Iss. 17
Closed Access | Times Cited: 55
Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches
Fereshteh Badie, Maryam Ghandali, Seyed Alireza Tabatabaei, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 44
Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
Shiqi Wang, Flavia Fontana, Mohammad‐Ali Shahbazi, et al.
Chemical Communications (2021) Vol. 57, Iss. 35, pp. 4212-4229
Open Access | Times Cited: 43
Prospects of Immunotherapy for Triple-Negative Breast Cancer
Dan Qiu, Guijuan Zhang, Xianxin Yan, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top